KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Intangibles (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Intangibles for 8 consecutive years, with $9.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Intangibles fell 20.32% to $9.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $9.6 million, a 20.32% decrease, with the full-year FY2024 number at $9.6 million, down 20.32% from a year prior.
  • Intangibles was $9.6 million for Q4 2024 at Biolife Solutions, down from $12.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $164.5 million in Q4 2021 to a low of $9.6 million in Q4 2024.
  • A 5-year average of $40.3 million and a median of $23.1 million in 2020 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: soared 429.69% in 2021, then tumbled 77.83% in 2023.
  • Biolife Solutions' Intangibles stood at $31.0 million in 2020, then skyrocketed by 429.69% to $164.5 million in 2021, then plummeted by 67.11% to $54.1 million in 2022, then crashed by 77.83% to $12.0 million in 2023, then decreased by 20.32% to $9.6 million in 2024.
  • Per Business Quant, the three most recent readings for BLFS's Intangibles are $9.6 million (Q4 2024), $12.0 million (Q4 2023), and $54.1 million (Q4 2022).